Lipopolysaccharide differentially alters systemic and brain glucocorticoid levels in neonatal and adult mice
Journal of Neuroendocrinology · 2025
DOI: 10.1111/jne.13481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2025. Verfasst von Jordan E Hamden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Lipopolysaccharides, Brain, Glucocorticoids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Glucocorticoids (GCs) are secreted by the adrenal glands and increase in response to stressors (e.g., infection). The brain regulates local GC levels via GC synthesis, regeneration and/or metabolism. Little is known about local GC regulation within discrete brain regions at baseline or in response to stress. We treated male and female C57BL/6J mice at postnatal day 5 (PND5) or PND90 with lipopolysaccharide (LPS; 50 μg/kg bw i.p.) or vehicle and collected blood and brain after 4 h. We microdissected the prefrontal cortex, hippocampus, hypothalamus and amygdala. We measured seven steroids, including corticosterone, via liquid chromatography–tandem mass spectrometry and measured transcripts for key steroidogenic enzymes ( Cyp11b1 , Hsd11b1 , Hsd11b2 ) via qPCR. At both ages, LPS increased GC levels in blood and all brain regions; however, the increases were much greater at PND90 than at PND5. Interestingly, PND5 corticosterone levels were lower in prefrontal cortex than in blood, but higher in amygdala than in blood. These changes in corticosterone levels align with local changes in steroidogenic enzyme expression, demonstrating robust regional heterogeneity and a possible mechanism for the region‐specific effects of early‐life stress. In contrast, PND90 corticosterone levels were lower in all brain regions than in blood and similar among regions, and steroidogenic enzyme mRNA levels were generally not affected by LPS. Together, these data indicate that local GC levels within discrete brain regions are more heterogeneous at baseline and in response to LPS at PND5 than at PND90, as a result of increased local GC production and metabolism in the neonatal brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
- Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Zoology, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada.
- Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Jordan E Hamden
Förderung
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Hamden, J. E., Salehzadeh, M., Bajaj, H., Li, M. X., & Soma, K. K. (2025). Lipopolysaccharide differentially alters systemic and brain glucocorticoid levels in neonatal and adult mice. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13481
Vancouver
Hamden JE, Salehzadeh M, Bajaj H, Li MX, Soma KK. Lipopolysaccharide differentially alters systemic and brain glucocorticoid levels in neonatal and adult mice. Journal of Neuroendocrinology. 2025. doi:10.1111/jne.13481
BibTeX
@article{Hamden2025,
author = {Hamden, Jordan E and Salehzadeh, Melody and Bajaj, Hitasha and Li, Michael X and Soma, Kiran K},
title = {Lipopolysaccharide differentially alters systemic and brain glucocorticoid levels in neonatal and adult mice},
journal = {Journal of Neuroendocrinology},
year = {2025},
doi = {10.1111/jne.13481}
}
EUVIMED